PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
1807413.38%
Cash & equivalents growing 1807413.38% while Healthcare shows decline of -0.44%. Warren Buffett would see this as a competitive advantage in maintaining liquidity while peers face cash constraints.
No Data
No Data available this quarter, please select a different quarter.
1807413.38%
Below half the Healthcare median of -0.47% yoy growth. Jim Chanos might see inadequate liquidity buildup relative to peers. Verify free cash flow trends.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1991465.49%
Current assets growth ≥ 1.5x the Healthcare median of 0.25%. Joel Greenblatt sees a potential liquidity edge if well allocated.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1993307.75%
≥ 1.5x the Healthcare median of 0.30%. Joel Greenblatt sees more aggressive asset expansion than peers, but must confirm returns are adequate.
9610300.00%
Payables growth above 1.5x Healthcare median of 0.00%. Jim Chanos might see a warning sign of stressed supplier payments.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6.78%
Above 1.5x Healthcare median of 0.97%. Jim Chanos suspects potential working capital strain.
2.24%
Above 1.5x Healthcare median of 0.00%. Jim Chanos might see a red flag for ballooning debt load.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.24%
Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects a red flag in ballooning future obligations.
No Data
No Data available this quarter, please select a different quarter.
3.56%
Above 1.5x Healthcare median of 0.38%. Jim Chanos suspects an alarming rise in overall leverage.
No Data
No Data available this quarter, please select a different quarter.
-1.35%
Below half Healthcare median of 0.00%. Jim Chanos suspects poor profitability or large dividend drains.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Above 1.5x Healthcare median of 0.00%. Jim Chanos sees a potential red flag for complicated equity transactions.
-3.71%
Below half Healthcare median of 0.73%. Jim Chanos suspects slower net worth growth or losses vs. peers.
-100.00%
Below half Healthcare median of 0.14%. Jim Chanos suspects a major slowdown or distress.
No Data
No Data available this quarter, please select a different quarter.
2.24%
Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects a big rise in leverage. Check coverage carefully.
-3606.58%
Below half of Healthcare median 0.58%. Joel Greenblatt sees stronger deleveraging or cash accumulation vs. peers.